144 related articles for article (PubMed ID: 25459147)
1. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
Mazumder MK; Borah A
Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147
[TBL] [Abstract][Full Text] [Related]
2. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
Kumar G; Patnaik R
Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252
[TBL] [Abstract][Full Text] [Related]
3. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
4. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
5. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.
Bhattacharya P; Pandey AK; Paul S; Patnaik R
Med Hypotheses; 2012 Oct; 79(4):516-8. PubMed ID: 22874452
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis.
Mazumder MK; Bhattacharya P; Borah A
Med Hypotheses; 2014 Dec; 83(6):697-701. PubMed ID: 25459137
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists.
Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C
Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918
[TBL] [Abstract][Full Text] [Related]
9. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
[TBL] [Abstract][Full Text] [Related]
10. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
[TBL] [Abstract][Full Text] [Related]
11. The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced neuroprotection in a rat subarachnoid hemorrhage model.
Zhang Z; Liu J; Fan C; Mao L; Xie R; Wang S; Yang M; Yuan H; Yang X; Sun J; Wang J; Kong J; Huang S; Sun B
Exp Neurol; 2018 Mar; 301(Pt A):13-25. PubMed ID: 29258835
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
14. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Karakas E; Simorowski N; Furukawa H
Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
[TBL] [Abstract][Full Text] [Related]
15. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
[TBL] [Abstract][Full Text] [Related]
16. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
18. Ifenprodil effects on GluN2B-containing glutamate receptors.
Amico-Ruvio SA; Paganelli MA; Myers JM; Popescu GK
Mol Pharmacol; 2012 Dec; 82(6):1074-81. PubMed ID: 22936815
[TBL] [Abstract][Full Text] [Related]
19. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor.
Wee XK; Ng KS; Leung HW; Cheong YP; Kong KH; Ng FM; Soh W; Lam Y; Low CM
Br J Pharmacol; 2010 Jan; 159(2):449-61. PubMed ID: 20082612
[TBL] [Abstract][Full Text] [Related]
20. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
